BCRX
BioCryst Pharmaceuticals, Inc. · Healthcare
President and CEO Jon P Stonehouse sold $3.9M of BioCryst Pharmaceuticals, Inc.
Sold$3,851,918
$12.94Price
297,573Shares
−25%Stake
What BCRX did after the filing
- The stock from Fri, Dec 2 close, $12.79
- −21.0%
- S&P 500, same days
- −3.3%
Measured over 30 trading days, to the Jan 18 close.
Traded Thu, Dec 1. Filed Fri, Dec 2, 1:33 PM ET, during the session. Returns use the Dec 2 close and the Jan 18 close. Not investment advice.